ResearcherNational Institutes of HealthNo recent work listed

Hua Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8809-7972, 0009-0007-8826-0876; OpenAlex author ID A5019764107. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. Co-author DOI 10.1038/s41467-023-37616-4 ↗
[Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA]. Co-author DOI 10.3760/cma.j.cn112152-20190313-00152 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

C F Wang · 1 shared paper, 2020 · strength 0.24
- Paper [Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA]. DOI 10.3760/cma.j.cn112152-20190313-00152 ↗
Stephen M. Hewitt · 1 shared paper, 2023 · strength 0.16
- Paper The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC… DOI 10.1038/s41467-023-37616-4 ↗
Nan Li · 1 shared paper, 2023 · strength 0.16
- Paper The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC… DOI 10.1038/s41467-023-37616-4 ↗
Mitchell Ho · 1 shared paper, 2023 · strength 0.16
- Paper The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC… DOI 10.1038/s41467-023-37616-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.